Skip to content

Clinical trials

Terminated Ovarian Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Terminated Country / region: United Kingdom Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20092
20112
20121
20145
20152
20161
20172
20182
20201
20216
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.3
Cancer Research UK2
Incyte Corporation2
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
AbbVie1
Almac Discovery1
Amgen1
Aravive, Inc.1
BerGenBio ASA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms33
Carcinoma, Non-Small-Cell Lung9
Breast Neoplasms6
Endometrial Neoplasms6
Fallopian Tube Neoplasms6
Stomach Neoplasms6
Uterine Cervical Neoplasms5
Triple Negative Breast Neoplasms4
Carcinoma, Ovarian Epithelial3
Carcinoma, Renal Cell3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.